Peanut Butter Products Recalled Across 40 States Due to Plastic Contamination | Peanut Butter Recall Expanded Due to Plastic Contamination | Peanut Butter Recall, Tech Conference, and Local Cincinnati News | FDA Escalates Cake Mix Recall Over Undeclared Milk Allergen | FDA Commissioner's Drug Review Plan Sparks Alarm | Legal Questions Swirl Around FDA’s New Expedited Drug Program | FDA Expands Pecorino Romano Cheese Recall Due to Listeria Concerns | FDA Announces Recall of Spring & Mulberry Chocolate Bars Due to Salmonella Risk | Peanut Butter Products Recalled Across 40 States Due to Plastic Contamination | Peanut Butter Recall Expanded Due to Plastic Contamination | Peanut Butter Recall, Tech Conference, and Local Cincinnati News | FDA Escalates Cake Mix Recall Over Undeclared Milk Allergen | FDA Commissioner's Drug Review Plan Sparks Alarm | Legal Questions Swirl Around FDA’s New Expedited Drug Program | FDA Expands Pecorino Romano Cheese Recall Due to Listeria Concerns | FDA Announces Recall of Spring & Mulberry Chocolate Bars Due to Salmonella Risk
A widespread recall has been issued for over 20,000 peanut butter products across 40 states due to potential plastic contamination. This affects various single-serve peanut butter and peanut butter and jelly packets, primarily distributed u...
More than 20,000 peanut butter products recalled across 40 states, including Wisconsin
More than 20,000 single-serve peanut butter products are being recalled across 40 states due to potential plastic contamination. Ventura Foods initiated the recall after discovering pieces of blue plastic in a filter at their production fac...
FDA peanut butter recall: Plastic could be in some Ventura Foods single-serve items, agency says
Stay informed about the latest happenings in Cincinnati, including a major peanut butter recall, the student-run TechOlympics IT conference, and other local headlines compiled by Yanuki using the latest trends and data.
CT included in FDA recall of 22,000 cases of peanut butter products across US
The U.S. Food and Drug Administration (FDA) has elevated a nationwide recall of cake and bread mixes to a Class I designation, its most serious warning, due to undeclared milk allergens. This poses a significant risk to individuals with mil...
Cake mixes now carry 'death' risk as FDA escalates recall to highest danger level over allergen
An expedited drug review program initiated by the FDA commissioner is generating internal apprehension due to concerns regarding potential conflicts with established legal, ethical, and scientific benchmarks. The program aims to accelerate...
Legal questions swirl around FDA's new expedited drug program, including who should sign off
The FDA’s expedited drug review program, championed by the previous administration, faces scrutiny over legal and ethical concerns. This initiative, designed to fast-track the approval of certain medications, has raised questions about the...
Some drugmakers quietly concerned about legal risk with speedy FDA review program
Several brands of Pecorino Romano cheese have been recalled across 20 states due to Listeria contamination, prompting the FDA to issue a Class I recall.
Cheese recalled in 20 states, including Oregon, bumped to highest FDA risk level due to listeria concerns
A nationwide recall has been issued for Spring & Mulberry Mint Leaf Date-Sweetened Chocolate Bars after routine testing revealed potential Salmonella contamination. This recall, announced by the FDA, affects products sold online and in sele...
Chocolate bars sold nationwide recalled for possible contamination
This article recaps Anna Wintour's recent appearance at the CFDA Fashion Awards and previews the upcoming Met Gala 2026 theme, offering insights into the evolving landscape of fashion and its intersection with art.
Anna Wintour attends the CFDA Fashion Awards in signature style
The Food and Drug Administration (FDA) has announced the removal of black box warnings from hormone replacement therapy (HRT) medications. These warnings, which cautioned about serious risks like breast cancer and heart attack, have been cr...
F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause
The Food and Drug Administration (FDA) is removing black box warnings on hormone therapy (HT) products prescribed for menopause symptoms. These warnings, which cautioned about potential risks like cancer, dementia, heart attack, and stroke,...
‘Black box’ safety warning to be removed from hormone therapy for menopause
Kelsea Ballerini is making waves with the release of her new EP, 'Mount Pleasant,' and her appearance at the CFDA Fashion Awards. Fans are eagerly anticipating her new music, while fashion enthusiasts are applauding her red carpet style.
Kelsea Ballerini Unveils New EP, ‘Mount Pleasant’, and Confirms Next Single, ‘I Sit in Parks’, is Dropping Tonight
Rihanna and A$AP Rocky made a glamorous return to the red carpet at the 2025 CFDA Fashion Awards in New York City. The event marked Rihanna's first public appearance since the birth of their daughter, Rocki Irish, and celebrated A$AP Rocky'...
Rihanna Rocks 'Postpartum-Forward Look' in First Red Carpet Post Baby with A$AP Rocky
Rihanna and A$AP Rocky made a dazzling appearance at the 2025 CFDA Fashion Awards in New York City. This marked Rihanna's first red carpet appearance since the birth of their daughter, Rocki Irish, in September. A$AP Rocky was honored with...
Rihanna Makes Red Carpet Return With A$AP Rocky After Giving Birth to Baby No. 3
uniQure (QURE) faces regulatory uncertainty as the FDA questions the adequacy of existing data for its Huntington’s disease gene therapy, AMT-130, potentially delaying its approval timeline. This shift in the FDA's stance has significantly...
Uniqure’s FDA submission for its Huntington’s disease therapy thrown into question
Dr. George Tidmarsh, the head of the Food and Drug Administration's (FDA) drug center, has resigned after federal officials initiated a review of 'serious concerns' regarding his conduct. This development follows allegations of a personal v...
F.D.A. Drug Unit Chief Resigns, and Is Sued by Drug Company
Several drugmakers have issued a voluntary recall of blood pressure medication prazosin hydrochloride due to potential contamination with a cancer-causing chemical. This action impacts over half a million bottles of the drug and raises conc...
FDA says drugmakers have recalled a blood pressure medicine tainted with a cancer-causing chemical
More than 580,000 bottles of Prazosin Hydrochloride, a widely used blood pressure medication, are being recalled across the United States. The recall is due to concerns that the medication contains unsafe levels of N-nitroso Prazosin, a che...
FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical
The FDA has approved a new hormone-free drug, elinzanetant (brand name Lynkuet), developed by Bayer, to alleviate moderate to severe hot flashes in menopausal women. This offers a new option for those who cannot or prefer not to use hormone...
FDA Approves New Menopause Drug to Treat Hot Flashes and Night Sweats